Publication
What M&A trends will transform the 2024 insurance landscape?
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Author:
Global | Publication | July 2016
Case: Sobeys West Inc et al v College of Pharmacists of British Columbia, leave to appeal with the Supreme Court of Canada (Docket 36917), 2016 BCCA 41, 2014 BCSC 1414
Nature of case: Leave to appeal with the Supreme Court of Canada
Successful party: College of Pharmacists of British Columbia
Date of decision: July 7, 2016
The College of Pharmacists of British Columbia (CPBC) is the regulatory body responsible for licensing and registering pharmacists, pharmacies and pharmacy technicians in British Columbia. The CPBC enacted bylaws that would prohibit pharmacists from providing “customer incentives programs” (including rebates, gifts, discounts, money, customer loyalty schemes, coupons, goods or rewards) to patients for filling a prescription or obtaining professional services from pharmacists. Sobeys West Inc., who operates pharmacies that offer such customer incentive programs, sought to quash the bylaws as being overbroad and unreasonable. The BC Supreme Court struck down the bylaws. The BC Court of Appeal allowed the appeal and set aside the decision of the lower court (reported here). Sobeys sought leave to appeal with the Supreme Court of Canada.
Sobey’s application for leave to appeal from the judgment of the BC Court of Appeal (2016 BCCA 1414) was dismissed with costs.
The CPBC bylaws prohibiting pharmacists from providing incentives remain in force.
In a parallel case in Alberta (Sobeys West Inc v Alberta College of Pharmacists, 2016 ABQB 232), Sobeys sought judicial review of amended provisions of the Alberta College of Pharmacists’ (ACP) Code of Ethics and Standards that prohibit customer incentives. The Court held that the APC had acted outside its legislated scope of authority by enacting the incentive prohibition (reported here).
The APC has sought appeal of the Court’s judgment (Court File No. 1603-0120AC). The APC’s appeal is currently pending and will likely be heard by the Alberta Court of Appeal in 2017.
Publication
It is widely accepted that 2023 was one of the worst years in recent memory for M&A activity.
Publication
The ongoing conflicts and further geopolitical tensions in Eastern Europe and the Middle East, coupled with upcoming elections in a number of key countries including the US and the UK, make 2024 challenging to predict what impact this will have on the insurance sector.
Publication
On 6 September 2022, the European Commission (EC) prohibited Illumina’s acquisition of Grail, bringing to an end the administrative stage of a legal saga that has attracted interest beyond competition law specialists.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023